崑崙萬維(300418.SZ):斥500萬美元認購夏爾巴投資發起設立的投資基金份額
格隆匯7月27日丨崑崙萬維(300418.SZ)公佈,為了推進公司整體戰略實施,公司全資子公司Kunlun Tech Limited以自有資金出資500萬美元認購Sherpa Healthcare Partners Co., Ltd.發起設立的股權投資基金,並簽署相關協議。基金名稱為Sherpa Healthcare Fund I, L.P.,目標認繳出資總額2億美元。
該基金主要投資於大中華區生物醫藥領域的公司,包括藥品、醫療設備、醫療保健服務(包括醫院)、醫療信息技術等領域。基金的普通合夥人為Sherpa Healthcare Fund I GP, Ltd.,基金管理人為Sherpa Healthcare Partners Co., Ltd.(下稱“夏爾巴投資”)。
夏爾巴投資是中國醫療健康領域有影響力的股權投資機構,在相關領域擁有高質量的人才儲備及豐富的行業投資經驗。公司參與認購夏爾巴投資發起設立的投資基金,有利於藉助專業投資機構的優勢,降低公司自身投資業務風險,把握優質賽道,為公司培育新的利潤增長點,是公司繼續踐行立足互聯網核心業務,投資互聯網AI(物聯網和人工智能)發展戰略的重要舉措。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.